Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CB Fleet voluntarily recalls OTC OSP

This article was originally published in The Tan Sheet

Executive Summary

CB Fleet, maker of the lone OTC oral sodium phosphate product, voluntarily recalls its Fleet Phospho-soda products following FDA's safety alert on the kidney injury risks associated with using the products for bowel cleansing. The recall "is directed to retailers and wholesalers" and Fleet decided "voluntarily to remove them from the market as expeditiously as possible," the Lynchburg, Va.-based firm says Dec. 11, referencing FDA's alert (1"The Tan Sheet" Dec. 15, 2008, p. 8). Fleet requests that consumers not purchase the OTC products for bowel cleansing and says to contact physicians for alternatives if an OTC is doctor-recommended

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts